Cytosorbents (CTSO) Total Non-Current Liabilities (2010 - 2017)

Cytosorbents (CTSO) has reported Total Non-Current Liabilities for 6 consecutive years, with $13.1 million the latest figure, recorded in Q2 2017.

• For the quarter ending Q2 2017, Total Non-Current Liabilities rose 87.33% year-over-year to $13.1 million; the trailing twelve-month figure through Jun 2017 stood at $13.1 million (up 87.33% YoY), and the FY2016 full-year result was $6.5 million, up 364.95% from the prior year.
• Total Non-Current Liabilities climbed to $13.1 million in Q2 2017 per CTSO's latest filing, from $8.2 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $13.1 million in Q2 2017 and bottomed at -$1.5 million in Q4 2014.
• Historically, Total Non-Current Liabilities has averaged $5.5 million across 4 years, with a median of $6.8 million in 2016.
• The widest YoY moves for Total Non-Current Liabilities: up 402.59% in 2017, down 87.33% in 2017.
• Over 4 years, Total Non-Current Liabilities stood at -$1.5 million in 2014, then soared by 196.59% to $1.4 million in 2015, then jumped by 364.95% to $6.5 million in 2016, then surged by 100.53% to $13.1 million in 2017.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $13.1 million, $8.2 million, and $6.5 million for Q2 2017, Q1 2017, and Q4 2016 respectively.